Novavax (NVAX) Tops Q4 EPS by 60c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.21 --0%
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
DIT, AMC, DPZ, More
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of $0.11, $0.60 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $147 million versus the consensus estimate of $90.25 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Reiterates Buy Rating on Tractor Supply Company (TSCO) Amid Soft Q2 Expectations
- Air Canada and Airbus plan C$13.7M sustainable fuel platform
- Dynex Capital (DX) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
